[unable to retrieve full-text content]Encouraged by Rwanda?s steady gains in curbing measles, donors are paying for a more expensive dual vaccine that will target rubella, too.
Source: http://www.nytimes.com/2013/02/26/health/after-measles-success-rwanda-to-get-rubella-vaccine.html?partner=rss&emc=rss
warren sapp the masters i robot the big c the visitor king of kings ostara
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.